Will begin treatments in the fall of 2025
A local treatment fund will be available to residents in Alberta
Insights from Gustaf Salford, president and CEO of Elekta
Does not significantly change cancer control or risk for side effects
Seeking to better understand treatment efficacy
Assessing the state of the proton market and its biggest players
Q&A with Dr. Jeff Michalski, president of ASTRO
First Alzheimer's patients enroll in study using Hyperfine's Swoop system
Cuts to radiation treatments are as much as 22%
Will invest in new radiation oncology equipment and patient care support services at the centers
Breast, and head and neck cancers are increasingly being treated with protons
Eliminates expensive system of crystals and photodetectors, cutting scanner price in half
Combines ultrahigh dose rates with Bragg Peak proton properties